us neuro img 1

Register to receive a free US Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices Market Report synopsis and brochure

The U.S. Food and Drug Administration (FDA) has recently announced its approval for Covidien’s Apollo Onyx Delivery Micro Catheter, a device designed for optimizing catheter retrieval in liquid embolization procedures of brain arteriovenous malformations (bAVMs). A bAVM refers to a condition in which a group of blood vessels evade brain tissue and bring blood from the arteries straight to the veins. The American Heart Association reports that as many as one in 200-500 people experience bAVMs.

“This new game-changing device will improve physicians’ options for treating patients with bAVMs,” said Dr. Alejandro Berenstein, director, Center for Endovascular Surgery at the Hyman-Newman Institute for Neurology and Neurosurgery at Mount Sinai Health Systems in New York City. “The Apollo Onyx micro catheter provides a very important added safety mechanism for catheter retrieval during Onyx LES embolizations of bAVMs, permitting a more complete treatment in a much safer manner.”

This product is that first of its kind in the U.S. that includes a detachable tip feature, which makes catheter retrieval easier in such small, delicate surroundings. Not only does this make treatment easier for the physician and more effective, but it results in better safety for the patient.

About Covidien
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading products in medical devices and supplies. With 2012 revenue of $9.9 billion, Covidien has 38,000 employees worldwide in 70 countries, and its products are sold in over 140 countries.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: